Fosun International LTD Ironwood Pharmaceuticals Inc Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$8.59 - $10.96 $3.78 Million - $4.82 Million	-439,853 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$9.8 - $12.89 $588,000 - $773,400	60,000 Added 15.8%	439,853 $4.76 Million
Q1 2019 May 10, 2019	BUY	$8.27 - $12.73 $265,897 - $409,294	32,152 Added 9.25%	379,853 $4.83 Million
Q3 2018 Nov 09, 2018	BUY	$14.31 - $17.65 $4.98 Million - $6.14 Million	347,701 New	347,701 $6.36 Million

245

163M

11.5M

12.9K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $216M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.